James C. Foster
Net Worth

Last updated:

What is James C. Foster net worth?

The estimated net worth of Mr. James C. Foster is at least $153,732,537 as of 29 Jan 2024. He owns shares worth $32,139,180 as insider, has earned $103,173,357 from insider trading and has received compensation worth at least $18,420,000 in Charles River Laboratories International, Inc..

What is the salary of James C. Foster?

Mr. James C. Foster salary is $3,070,000 per year as Chairman, Chief Executive Officer & Pres in Charles River Laboratories International, Inc..

How old is James C. Foster?

Mr. James C. Foster is 74 years old, born in 1951.

What stocks does James C. Foster currently own?

As insider, Mr. James C. Foster owns shares in one company:

Company Title Shares Price per share Total value
Charles River Laboratories International, Inc. (CRL) Chairman, Chief Executive Officer & Pres 202,643 $158.6 $32,139,180

What does Charles River Laboratories International, Inc. do?

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodent research model strains and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening non-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of non-clinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies; and avian vaccine services that provide specific-pathogen-free (SPF) fertile chicken eggs, SPF chickens, and diagnostic products used to manufacture vaccines. The company also provides contract vivarium operation services to biopharmaceutical clients. Charles River Laboratories International, Inc. was founded in 1947 and is headquartered in Wilmington, Massachusetts.

James C. Foster insider trading

Charles River Laboratories International, Inc.

Mr. James C. Foster has made 68 insider trades between 2019-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 47,303 units of CRL stock on 24 Feb 2020. As of 29 Jan 2024 he still owns at least 202,643 units of CRL stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock Options (Right to Buy) 17,436 $144.67 $2,522,466
Option
Common Stock 17,436 $144.67 $2,522,466
Purchase
Common Stock 5,620 $178.05 $1,000,641
Sale
Common Stock 108 $250.16 $27,017
Sale
Common Stock 19,892 $250 $4,973,000
Sale
Common Stock 389 $294.7 $114,637
Sale
Common Stock 746 $292.87 $218,479
Option
Stock Options (Right to Buy) 17,436 $144.67 $2,522,466
Sale
Common Stock 3,171 $287.1 $910,388
Option
Common Stock 20,296 $109.34 $2,219,165
Sale
Common Stock 805 $288.82 $232,501
Sale
Common Stock 1,078 $290.01 $312,633
Sale
Common Stock 3,415 $284.79 $972,544
Sale
Common Stock 1,503 $283.89 $426,684
Sale
Common Stock 1,259 $291.05 $366,437
Sale
Common Stock 981 $291.81 $286,263
Sale
Common Stock 352 $295.7 $104,085
Sale
Common Stock 325 $293.81 $95,489
Sale
Common Stock 2,027 $286.06 $579,846
Option
Stock Options (Right to Buy) 20,296 $109.34 $2,219,165
Sale
Common Stock 4,245 $287.84 $1,221,889
Sale
Common Stock 4,472 $288.86 $1,291,764
Sale
Common Stock 2,600 $290.03 $754,086
Sale
Common Stock 350 $292.74 $102,460
Sale
Common Stock 1,481 $290.89 $430,802
Sale
Common Stock 2,394 $286.93 $686,920
Option
Common Stock 17,436 $144.67 $2,522,466
Sale
Common Stock 796 $285.88 $227,560
Sale
Common Stock 5,243 $288.12 $1,510,587
Sale
Common Stock 100 $291.5 $29,150
Sale
Common Stock 914 $331.43 $302,931
Sale
Common Stock 325 $308.23 $100,174
Sale
Common Stock 1,064 $309.37 $329,164
Sale
Common Stock 2,456 $310.35 $762,227
Sale
Common Stock 1,643 $311.3 $511,466
Sale
Common Stock 15 $334.06 $5,011
Sale
Common Stock 236 $333.29 $78,657
Sale
Common Stock 51 $332.63 $16,964
Sale
Common Stock 465 $330.16 $153,526
Sale
Common Stock 158 $329.12 $52,001
Sale
Common Stock 98 $328.5 $32,193
Sale
Common Stock 179 $326.88 $58,511
Sale
Common Stock 174 $323.07 $56,214
Sale
Common Stock 100 $321.93 $32,193
Sale
Common Stock 420 $320.23 $134,496
Sale
Common Stock 325 $317.98 $103,344
Sale
Common Stock 1,243 $317.06 $394,103
Sale
Common Stock 2,157 $316.34 $682,354
Sale
Common Stock 1,816 $315.15 $572,314
Sale
Common Stock 2,812 $314.43 $884,180
Sale
Common Stock 1,514 $313.24 $474,245
Sale
Common Stock 1,835 $312.19 $572,872
Sale
Common Stock 10,000 $402.86 $4,028,580
Sale
Common Stock 9,577 $334.05 $3,199,197
Option
Common Stock 9,577 N/A N/A
Sale
Common Stock 9,577 N/A N/A
Option
Stock Options (Right to Buy) 9,577 N/A N/A
Sale
Common Stock 7,500 $343.64 $2,577,308
Sale
Common Stock 24,009 $206.76 $4,964,125
Option
Stock Options (Right to Buy) 24,009 N/A N/A
Option
Common Stock 24,009 $88.05 $2,113,992
Sale
Common Stock 24,009 $284.46 $6,829,648
Sale
Common Stock 20,295 $185.95 $3,773,936
Option
Stock Options (Right to Buy) 20,295 $109.34 $2,219,055
Option
Common Stock 20,295 N/A N/A
Sale
Common Stock 20,295 $278.98 $5,661,919
Sale
Common Stock 17,436 $235.86 $4,112,368
Option
Common Stock 17,436 N/A N/A
Option
Stock Options (Right to Buy) 17,436 N/A N/A
Sale
Common Stock 30,000 $285.21 $8,556,180
Sale
Common Stock 22,000 $233.09 $5,127,892
Sale
Common Stock 24,000 $217.06 $5,209,344
Option
Stock Options (Right to Buy) 17,435 $144.67 $2,522,321
Option
Common Stock 17,435 $144.67 $2,522,321
Sale
Common Stock 17,435 $175 $3,051,125
Sale
Common Stock 17,446 $162.75 $2,839,302
Sale
Common Stock 25,124 $162.29 $4,077,324
Option
Common Stock 25,124 $73.7 $1,851,639
Option
Stock Options (Right to Buy) 25,124 $73.7 $1,851,639
Sale
Common Stock 47,303 $167.59 $7,927,557
Option
Stock Options (Right to Buy) 44,303 $98.7 $4,372,485
Option
Common Stock 44,303 $98.7 $4,372,485
Sale
Common Stock 15,000 $172.1 $2,581,560
Option
Stock Options (Right to Buy) 21,577 $76.67 $1,654,309
Sale
Common Stock 21,577 $141.25 $3,047,665
Sale
Common Stock 19,828 $141.24 $2,800,527
Option
Common Stock 21,577 $76.67 $1,654,309
Sale
Common Stock 1,409 $139.94 $197,174
Option
Stock Options (Right to Buy) 25,123 $73.7 $1,851,565
Sale
Common Stock 779 $139.93 $109,007
Option
Common Stock 25,123 $73.7 $1,851,565
Sale
Common Stock 559 $139.89 $78,201
Sale
Common Stock 1,709 $139.88 $239,058

Charles River Laboratories International key executives

Charles River Laboratories International, Inc. executives and other stock owners filed with the SEC: